SCHEMBL19977977

SCHEMBL19977977

C=C(N)/C=C\C(=C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19661047 0.82
SCHEMBL14043649 0.73
SCHEMBL13844882 0.71
SCHEMBL13926008 0.69
SCHEMBL14996695 0.69
SCHEMBL15764321 0.69
SCHEMBL18855272 0.69
SCHEMBL14339632 0.69
SCHEMBL13679279 0.69
SCHEMBL21973918 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024031002-A1 (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS CORTEVA AGRISCIENCE LLC (US) 2024-02-08 WO disclosed
US-11180497-B2 Cyclic compounds as immunomodulating agents ANGEX PHARMACEUTICAL, INC. (US) 2021-11-23 US disclosed
US-10946013-B2 Methods for treating central nervous system disorders using vdac inhibitors The National Institute for Biotechnology in the Negev Ltd. (IL) 2021-03-16 US disclosed
US-20200276180-A1 POLYCYCLIC COMPOUND ACTING AS IDO INHIBITOR AND/OR IDO-HDAC DUAL INHIBITOR HANGZHOU INNOGATE PHARMA CO., LTD (CN) 2020-09-03 US disclosed
US-20200239464-A1 CYCLIC COMPOUNDS AS IMMUNOMODULATING AGENTS ANGEX PHARMACEUTICAL, INC. 2020-07-30 US disclosed
US-10508091-B2 Piperazine and piperidine derivatives, their synthesis and use thereof in inhibiting VDAC oligomerization, apoptosis and mitochondria dysfunction The National Institute for Biotechnology in the Negev Ltd. (IL) 2019-12-17 US disclosed
US-10434099-B2 Methods for treating central nervous system disorders using VDAC inhibitors The National Institute for Biotechnology in the Negev Ltd. (IL) 2019-10-08 US disclosed
US-20180118700-A1 NOVEL PIPERAZINE AND PIPERIDINE DERIVATIVES, THEIR SYNTHESIS AND USE THEREOF IN INHIBITING VDAC OLIGOMERIZATION, APOPTOSIS AND MITOCHONDRIA DYSFUNCTION The National Institute for Biotechnology in the Negev Ltd. (IL) 2018-05-03 US disclosed
US-20180078548-A1 Methods for Treating Central Nervous System Disorders Using VDAC Inhibitors The National Institute for Biotechnology in the Negev Ltd. (IL) 2018-03-22 US disclosed